Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors von Strosberg, Jonathan, El-Haddad, Ghassan, Wolin, Edward, Hendifar, Andrew, Yao, James, Chasen, Beth, Mittra, Erik, Kunz, Pamela L, Kulke, Matthew H, Jacene, Heather, Bushnell, David, O’Dorisio, Thomas M, Baum, Richard P, Kulkarni, Harshad R, Caplin, Martyn, Lebtahi, Rachida, Hobday, Timothy, Delpassand, Ebrahim, Van Cutsem, Eric, Benson, Al, Srirajaskanthan, Rajaventhan, Pavel, Marianne, Mora, Jaime, Berlin, Jordan, Grande, Enrique, Reed, Nicholas, Seregni, Ettore, Öberg, Kjell, Lopera Sierra, Maribel, Santoro, Paola, Thevenet, Thomas, Erion, Jack L, Ruszniewski, Philippe, Kwekkeboom, Dik, Krenning, Eric

Volltext

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors von Ozdemir, Nuriye, Yazici, Ozan, Zengin, Nurullah, Yang, Feng, Jin, Chen, Fu, Deliang, Caplin, Martyn E, Pavel, Marianne, Ruszniewski, Philippe

Volltext

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors von Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Blumberg, Joëlle, Ruszniewski, Philippe

Volltext

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome von Kulke, Matthew H, Hörsch, Dieter, Caplin, Martyn E, Anthony, Lowell B, Bergsland, Emily, Öberg, Kjell, Welin, Staffan, Warner, Richard R P, Lombard-Bohas, Catherine, Kunz, Pamela L, Grande, Enrique, Valle, Juan W, Fleming, Douglas, Lapuerta, Pablo, Banks, Phillip, Jackson, Shanna, Zambrowicz, Brian, Sands, Arthur T, Pavel, Marianne

Volltext

Diagnostic and therapeutic advances in neuroendocrine tumours von Caplin, Martyn E., Ratnayake, Gowri M.

Volltext

Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement von Davar, Joseph, Connolly, Heidi M, Caplin, Martyn E, Pavel, Marianne, Zacks, Jerome, Bhattacharyya, Sanjeev, Cuthbertson, Daniel J, Dobson, Rebecca, Grozinsky-Glasberg, Simona, Steeds, Richard P, Dreyfus, Giles, Pellikka, Patricia A, Toumpanakis, Christos

Volltext

Update on the Role of Somatostatin Analogs for the Treatment of Patients With Gastroenteropancreatic Neuroendocrine Tumors von Toumpanakis, Christos, Caplin, Martyn E

Volltext

Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors von Wild, Damian, Bomanji, Jamshed B, Benkert, Pascal, Maecke, Helmut, Ell, Peter J, Reubi, Jean Claude, Caplin, Martyn E

Volltext

Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients? von Caplin, Martyn E.

Volltext

Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors von KHAN, Mohid S, KIRKWOOD, Amy, TSIGANI, Theodora, GARCIA-HERNANDEZ, Jorge, HARTLEY, John A, CAPLIN, Martyn E, MEYER, Tim

Volltext

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study von Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Gomez-Panzani, Edda, Ruszniewski, Philippe

Volltext

Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score von Chan, David L., Hayes, Aimee R., Karfis, Ioannis, Conner, Alice, Furtado O’Mahony, Luke, Mileva, Magdalena, Bernard, Elizabeth, Roach, Paul, Marin, Gwennaëlle, Pavlakis, Nick, Schembri, Geoffrey, Gnanasegaran, Gopinath, Marin, Clementine, Vanderlinden, Bruno, Navalkissoor, Shaunak, Caplin, Martyn E., Flamen, Patrick, Toumpanakis, Christos, Bailey, Dale L.

Volltext

Recommendations for management of patients with neuroendocrine liver metastases von Frilling, Andrea, Prof, Modlin, Irvin M, Prof, Kidd, Mark, PhD, Russell, Christopher, Prof, Breitenstein, Stefan, MD, Salem, Riad, Prof, Kwekkeboom, Dik, MD, Lau, Wan-yee, Prof, Klersy, Catherine, MD, Vilgrain, Valerie, Prof, Davidson, Brian, Prof, Siegler, Mark, Prof, Caplin, Martyn, Prof, Solcia, Enrico, Prof, Schilsky, Richard, Prof

Volltext

Prostate cancer and the influence of dietary factors and supplements: a systematic review von Mandair, Dalvinder, Rossi, Roberta Elisa, Pericleous, Marinos, Whyand, Tara, Caplin, Martyn Evan

Volltext

Carcinoid Heart Disease von BHATTACHARYYA, Sanjeev, DAVAR, Joseph, DREYFUS, Gilles, CAPLIN, Martyn E

Volltext

Diet and supplements and their impact on colorectal cancer von Pericleous, Marinos, Mandair, Dalvinder, Caplin, Martyn E

Volltext

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors von Dromain, Clarisse, Pavel, Marianne E, Ruszniewski, Philippe, Langley, Alison, Massien, Christine, Baudin, Eric, Caplin, Martyn E

Volltext

Risk Factors for the Development and Progression of Carcinoid Heart Disease von Bhattacharyya, Sanjeev, MBChB, Toumpanakis, Christos, PhD, Chilkunda, Deepika, MBBS, Caplin, Martyn Evan, MD, Davar, Joseph, PhD

Volltext

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study von Caplin, Martyn E., Pavel, Marianne, Phan, Alexandria T., Ćwikła, Jarosław B., Sedláčková, Eva, Thanh, Xuan-Mai Truong, Wolin, Edward M., Ruszniewski, Philippe

Volltext

Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms von Khan, Mohid S, Kirkwood, Amy A, Tsigani, Theodora, Lowe, Helen, Goldstein, Robert, Hartley, John A, Caplin, Martyn E, Meyer, Tim

Volltext